GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,388.50p
   
  • Change Today:
    -61.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,108.34m
  • Volume: 2,424,649
  • Market Cap: £57,044m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
2.88% below the market average2.88% below the market average2.88% below the market average2.88% below the market average2.88% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr Revenue Growth
3.78% below the market average3.78% below the market average3.78% below the market average3.78% below the market average3.78% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
14.12% above the market average14.12% above the market average14.12% above the market average14.12% above the market average14.12% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
5.19% above the market average5.19% above the market average5.19% above the market average5.19% above the market average5.19% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
5.89% below the market average5.89% below the market average5.89% below the market average5.89% below the market average5.89% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average
Price Book Ratio
78.29% below the market average78.29% below the market average78.29% below the market average78.29% below the market average78.29% below the market average
36.59% below the sector average36.59% below the sector average36.59% below the sector average36.59% below the sector average36.59% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
12.22% below the market average12.22% below the market average12.22% below the market average12.22% below the market average12.22% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
Price Chg 3m
0.19% below the market average0.19% below the market average0.19% below the market average0.19% below the market average0.19% below the market average
20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
7.03% above the market average7.03% above the market average7.03% above the market average7.03% above the market average7.03% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Momentum 20
88.83% below the market average88.83% below the market average88.83% below the market average88.83% below the market average88.83% below the market average
91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.98% above the market average17.98% above the market average17.98% above the market average17.98% above the market average17.98% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
ROCE
68.71% above the market average68.71% above the market average68.71% above the market average68.71% above the market average68.71% above the market average
Sector averageSector averageSector averageSector averageSector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.89% above the market average91.89% above the market average91.89% above the market average91.89% above the market average91.89% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Forecast EPS
78.77% above the market average78.77% above the market average78.77% above the market average78.77% above the market average78.77% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.85% above the market average97.85% above the market average97.85% above the market average97.85% above the market average97.85% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
Operating Profit Loss
98.10% above the market average98.10% above the market average98.10% above the market average98.10% above the market average98.10% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Cash
96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
73.33% above the market average73.33% above the market average73.33% above the market average73.33% above the market average73.33% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Buys 1y
99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
94.67% below the market average94.67% below the market average94.67% below the market average94.67% below the market average94.67% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
73.09% above the market average73.09% above the market average73.09% above the market average73.09% above the market average73.09% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,388.50p
Change Today -61.50p
% Change -4.24 %
52 Week High 1,812.50
52 Week Low 1,264.00
Volume 2,424,649
Shares Issued 4,108.34m
Market Cap £57,044m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.48% below the market average41.48% below the market average41.48% below the market average41.48% below the market average41.48% below the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Price Trend
6.80% above the market average6.80% above the market average6.80% above the market average6.80% above the market average6.80% above the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Income
70.11% above the market average70.11% above the market average70.11% above the market average70.11% above the market average70.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.41% below the market average42.41% below the market average42.41% below the market average42.41% below the market average42.41% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 07-May-2025

Time Volume / Share Price
11:21 7 @ 1,389.00p
11:21 167 @ 1,388.41p
11:21 0 @ 1,388.50p
11:21 285 @ 1,388.50p
11:20 7 @ 1,388.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page